0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Many Roles of CCL20: Emphasis on Breast Cancer.

      Read this article at

      ScienceOpenPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          CCL20 or MIP3α is a small ~8 kDa protein primarily expressed in the liver, colon, prostate, cervix, and skin. The cellular receptor for CCL20 is CCR6. CCl20 unlike many other cytokines only binds CCR6, making the CCL20/CCR6 pathway an attractive drug target. Since the initial discovery of CCL20 in the early 1990's, there has been an increase in the evidence implicating the chemokine and its receptor in a number of diseases, including rheumatoid arthritis and human immunodeficiency virus infection. CCL20 has also been linked to malignancies such as ovarian, colorectal and pancreatic cancers. CCL20 can also attract tumor-promoting immune-suppressive cells to the tumor microenvironment, which may contribute to the immune evasive potential of the tumor and tumor progression.

          Related collections

          Author and article information

          Journal
          Postdoc J
          Postdoc journal : a journal of postdoctoral research and postdoctoral affairs
          2328-9791
          2328-9791
          Mar 2014
          : 2
          : 3
          Affiliations
          [1 ] Wayne State University, Department of Pharmacology, School of Medicine, 540 E Canfield,Detroit, MI 48201, USA.
          Article
          NIHMS810788
          5019369
          27631019

          breast cancer, CCL20, CCR6, MIP3α, chemokines

          Comments

          Comment on this article